ARTEMIS GLOBAL LIFE SCIENCES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - INR | -.--% |
|
-.--% | -.--% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2018 | 5.03B 60.24M 82.27M | Sales 2019 | 5.47B 65.48M 89.43M | Capitalization | 3.96B 47.4M 64.74M |
|---|---|---|---|---|---|
| Net income 2018 | 263M 3.15M 4.3M | Net income 2019 | 205M 2.46M 3.35M | EV / Sales 2018 | 1.44 x |
| Net Debt 2018 | 775M 9.28M 12.68M | Net Debt 2019 | 1.02B 12.2M 16.66M | EV / Sales 2019 | 0.91 x |
| P/E ratio 2018 |
24.6
x | P/E ratio 2019 |
19.4
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
Artemis Global Life Sciences Limited is an India-based company engaged in the business of buying, selling, managing, improving, maintaining, taking on lease, promoting, administer, own or run hospitals, clinics, nursing homes, dispensaries. It is also engaged in the business of maternity homes, old age homes, health resorts and health clubs, polyclinics, medical centers, child welfare and family planning centers, diagnostic centers. The Company is also into all types of laboratories for carrying on investigation, x-ray, CAT scan, ECG and medical research and provision of all kinds of medical and health services and equipments. The objective of the Company is to buy, sell, manufacture or deal in all type of drugs, medicines including alternative/Ayurveda medicines pharmaceuticals, chemicals and colors used in drugs, medicines and pharmaceuticals and in their raw materials.
Sector
-
- Stock Market
- Equities
- AGLSL Stock